In KPDM patients, the best predictors of insulin discontinuation are (i) presenting with new-onset diabetes and (ii) maintaining higher β-cell function reserves (as measured by the C-peptide-to-glucose ratio) [11]. The gene discussed is INS; the disease is diabetes mellitus.